Current and historical daily PE Ratio for IART (
Integra Lifesciences Holdings Corp
) from 1995 to Apr 25 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Integra Lifesciences stock (IART) PE ratio as of Apr 25 2024 is 34.08.
More Details
Integra Lifesciences Holdings Corp (IART) PE Ratio (TTM) Chart
Integra Lifesciences Holdings Corp (IART) PE Ratio (TTM) Historical Data
View and export this data going back to 1995. Start your Free Trial
Total 1215
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Integra Lifesciences PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-25 | 34.1 | 2024-02-21 | 53.9 |
| 2024-04-24 | 35.4 | 2024-02-20 | 54.5 |
| 2024-04-23 | 35.4 | 2024-02-16 | 54.3 |
| 2024-04-22 | 34.9 | 2024-02-15 | 53.9 |
| 2024-04-19 | 34.5 | 2024-02-14 | 52.6 |
| 2024-04-18 | 38.1 | 2024-02-13 | 51.5 |
| 2024-04-17 | 38.5 | 2024-02-12 | 52.9 |
| 2024-04-16 | 38.3 | 2024-02-09 | 51.1 |
| 2024-04-15 | 38.6 | 2024-02-08 | 50.3 |
| 2024-04-12 | 39.5 | 2024-02-07 | 49.6 |
| 2024-04-11 | 39.9 | 2024-02-06 | 49.4 |
| 2024-04-10 | 41.1 | 2024-02-05 | 47.6 |
| 2024-04-09 | 41.7 | 2024-02-02 | 48.4 |
| 2024-04-08 | 41.5 | 2024-02-01 | 49.3 |
| 2024-04-05 | 41.0 | 2024-01-31 | 48.4 |
| 2024-04-04 | 40.7 | 2024-01-30 | 49.2 |
| 2024-04-03 | 40.8 | 2024-01-29 | 50.5 |
| 2024-04-02 | 40.4 | 2024-01-26 | 50.4 |
| 2024-04-01 | 41.8 | 2024-01-25 | 50.4 |
| 2024-03-28 | 42.7 | 2024-01-24 | 49.9 |
| 2024-03-27 | 42.0 | 2024-01-23 | 50.9 |
| 2024-03-26 | 40.7 | 2024-01-22 | 51.9 |
| 2024-03-25 | 40.2 | 2024-01-19 | 51.1 |
| 2024-03-22 | 40.7 | 2024-01-18 | 51.1 |
| 2024-03-21 | 41.5 | 2024-01-17 | 50.5 |
| 2024-03-20 | 41.1 | 2024-01-16 | 50.6 |
| 2024-03-19 | 41.4 | 2024-01-12 | 51.7 |
| 2024-03-18 | 41.3 | 2024-01-11 | 52.2 |
| 2024-03-15 | 41.8 | 2024-01-10 | 52.4 |
| 2024-03-14 | 42.0 | 2024-01-09 | 52.4 |
| 2024-03-13 | 43.1 | 2024-01-08 | 52.2 |
| 2024-03-12 | 43.2 | 2024-01-05 | 50.7 |
| 2024-03-11 | 43.6 | 2024-01-04 | 49.9 |
| 2024-03-08 | 44.3 | 2024-01-03 | 49.2 |
| 2024-03-07 | 43.5 | 2024-01-02 | 52.1 |
| 2024-03-06 | 43.5 | 2023-12-29 | 52.5 |
| 2024-03-05 | 44.0 | 2023-12-28 | 52.9 |
| 2024-03-04 | 43.3 | 2023-12-27 | 36.3 |
| 2024-03-01 | 43.4 | 2023-12-26 | 36.7 |
| 2024-02-29 | 44.5 | 2023-12-22 | 36.9 |
| 2024-02-28 | 46.6 | 2023-12-21 | 36.7 |
| 2024-02-27 | 53.3 | 2023-12-20 | 35.6 |
| 2024-02-26 | 53.2 | 2023-12-19 | 35.9 |
| 2024-02-23 | 53.9 | 2023-12-18 | 35.4 |
| 2024-02-22 | 54.0 | 2023-12-15 | 35.4 |
Integra Lifesciences Holdings Corp (IART) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Integra Lifesciences Holdings Corp
NAICS : 339112
SIC : 3841
ISIN : US4579852082
Share Class Description:
IART: Ordinary SharesDescription
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers